← Back to headlines
AbbVie Reports Successful Late-Stage Trial for Multiple Myeloma Treatment
The pharmaceutical company announced positive results from its final clinical testing phase for a new therapy targeting multiple myeloma, advancing potential options for blood cancer patients.
3 Sept, 14:16 — 3 Sept, 14:16
Sources
Showing 1 of 1 sources
